UC HEALTH LINE: Women's Health Focus of UC Health Wellness Event
CINCINNATIWhen J.J. JioDucci experienced unexplained vaginal bleeding, the possibility of cancer never crossed her mind.
"The bleeding happened several times, but I thought it was the start of menopause, says JioDucci, 52, of Madisonville.
It wasnt until the bleeding became severe that JioDucci thought to herself that something might be terribly wrong.
Women are notorious for ignoring what their body is trying to tell them and for putting the needs of others in front of their own. But when it comes to health, University of Cincinnati (UC) experts say, women need to put themselves front and center.
Experts from UC Health will be on hand Saturday, April 10, from 9 a.m. to 1 p.m. at the UC Health West Chester Campus (7700 University Court) to discuss a number of womens health topics and answer questions.
A series of seminars will cover:
Managing menopause symptoms
Breast cancer risks
Breast screening guidelines
Infertilitycauses and treatments
Incontinence and pelvic organ prolapse
Minimally invasive surgery in gynecology
Options for breast and body enhancement
UC Health physicians making presentations include Krystene Boyle DiPaola, MD, Kellie Flood-Shaffer, MD, Mary South, MD, John Kitzmiller, MD, Su-Ju Lee, MD, Steven Lindheim, MD, W. Edward Richards, MD, and Elizabeth Shaughnessy, MD.
"Women cant care for others if they arent well themselves, says Richards. "Its important that they take time to listen to their bodies and fit in regular exams.
Attendees at the Womens Wellness Event will be eligible for prizes and will also have the opportunity to tour the new womens imaging center. Food will be provided. Space is limited. Call (513) 475-8030 to reserve a seat.
W. Edward Richards, MD, consulting with nursing staff at the UC Barrett Cancer Institute at University Hospital about a patient.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.